R1- QUANTIFYING THE IMPACT OF INTERACTIONS BETWEEN HMG-COA REDUCTASE INHIBITORS (STATINS) AND CYTOCHROME P-450 INTERACTING DRUGS ON HEALTHCARE UTILIZATION- A POPULATION-BASED STUDY
Mar 1, 2000, 00:00 AM
10.1016/S1098-3015(11)70322-9
https://www.valueinhealthjournal.com/article/S1098-3015(11)70322-9/fulltext
Section Title :
Section Order :
174
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)70322-9&doi=10.1016/S1098-3015(11)70322-9